Joint Formulary & PAD

Fluticasone (Flixotide Accuhaler / Evohaler) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :
Important

Flixotide Accuhaler - specialist paediatric recommendation. 50 and 100mcg strength only.

Children only - ICS alone not recommended in adults with asthma.

Prescribe by BRAND

 

Status 2

Blue
Formulations :
  • Inhaler (Metered Dose)
Associated Icons :
Restrictions / Comments :
Important

Flixotide Evohaler - specialist paediatric recommendation. 50 and 125 mcg strength only.

Children only - ICS alone not recommended in adults with asthma.

Prescribe by BRAND

PAD Profile

ChemicalSubstance :
Fluticasone (Flixotide Accuhaler / Evohaler)
Indication :
Asthma
Group Name :
ICS
Keywords :
ICS, inhaled corticosteroids, respiratory, asthmatics
Brand Names Include :
Flixotide Accuhaler, Flixotide Evohaler
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
9
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Fluticasone (Flixotide Accuhaler / Evohaler) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (1)

Flixotide Evohaler and Flixotide Accuhaler are not locally recommended. They are less cost effective and carry the risk of excess steroid dosing due to dose equivalence / potency compared to beclometasone
(500microgram of fluticasone propionate is equivalent to 1000micrograms beclometasone dipropionate)

Inhaler devices should be presrcibed by BRAND

See asthma guidelines and other resources below